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HUBUNG KAIT MASA TINDAK BALAS AMBULAN DAN KESAN BURUK 
MAJOR JANTUNG DALAM SINDROM KORONARI AKUT 
ABSTRAK 
Latar Belakang: Satu prinsip yang lazim dalam perkhidmatan perubatan kecemasan 
(EMS) menggariskan bahawa masa tindak balas yang lebih cepat adalah setara dengan 
hasil yang lebih baik pada pesakit yang mempunyai sindrom koronari akut (ACS). 
Kajian ini meneroka hubungan kait masa tindak balas ambulan (ART) dan kesan buruk 
major jantung (MACE) pada pesakit yang didiagnosis dengan ACS di Malaysia. 
Metodologi: Kajian ini merupakan kajian analisis kohort retrospektif yang dijalankan 
dari tahun 2014 hingga 2016 yang mana melibatkan dua perkhidmatan perubatan 
kecemasan (EMS) di Malaysia. Pesakit dewasa yang didiagnosis dengan ACS dan 
menggunakan EMS untuk ke hospital dikenalpasti untuk menilai MACE dalam tempoh 
30 dan 90 hari daripada peristiwa primer. Analisis regresi logistik ‘multivariable’ telah 
dijalankan untuk menilai interaksi di antara ART dan MACE. Keputusan: Seratus 
orang pesakit dengan purata umur 59.7 (SD = 12.7) tahun dimasukkan dalam analisis. 
Kadar purata ART ialah 21.7 (SD = 10.4) minit. 29 orang pesakit mendapat MACE 
dalam tempoh 30 hari manakala 40 orang pesakit mendapat MACE pada 90 hari 
selepas ACS. Kajian menunjukkan tiada hubung kait yang signifikan di antara ART dan 
berlakunya MACE 30 dan 90 hari selepas ACS (OR = 0.99, 95% CI: 0.95, 1.03; P = 
0.679 dan OR = 0.98; 95% CI: 0.95, 1.02; P = 0.446 ). Kesimpulan: Masa tindak 
balas ambulans (ART) tidak mempunyai hubung kait yang signifikan dengan MACE 
dalam tempoh 30 dan 90 hari selepas berlakunya ACS. Hasil kajian ini menggariskan 
keperluan untuk memastikan pengangkutan pesakit ACS dengan ambulan adalah pada 
kelajuan biasa dan mematuhi undang-undang jalan raya. 
Kata Kunci : Masa tindak balas ambulan, simdrom koronari akut, MACE 
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ASSOCIATION OF AMBULANCE RESPONSE TIME AND MAJOR ADVERSE 
CARDIAC EVENTS IN ACUTE CORONARY SYNDROME 
ABSTRACT 
Background: A common tenet in emergency medical service is that a faster response 
time equates to a better outcome in patients with acute coronary syndrome (ACS). We 
explored the association between ambulance response time (ART) and major adverse 
cardiac events (MACE) in patients diagnosed of ACS in Malaysia. Methods: This 
study was a retrospective cohort analysis conducted from 2014 until 2016 involving two 
emergency medical services (EMS) in Malaysia. Adult patients diagnosed with ACS 
and utilized the EMS to come to hospital were followed up to assess MACE within 30 
and 90 days from the primary event. Multivariable logistic regression analysis was 
performed to evaluate the interaction between ART and MACE. Results: One hundred 
patients with an average age of 59.7 (SD=12.7) years old were included in the analysis. 
The average ART was 21.7 (SD=10.4) minutes. 29 patients developed MACE at 30 
days and 40 patients developed MACE at 90 days post ACS. No significant association 
was found between ART and occurrence of MACE 30 and 90 days post ACS (OR= 
0.99; 95% CI: 0.95, 1.03; P=0.679 and OR=0.98; 95% CI: 0.95, 1.02; P=0.446 
respectively). Conclusion: ART was not significantly associated with MACE after both 
30 and 90 days onset of ACS. This underscores the need for not driving ambulances 
with high speeds when responding to ACS cases. 
Keywords: Ambulance response time, Acute Coronary Syndrome, Major Adverse 
Cardiac Event 
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Chapter 1 
Introduction 
1.1 Background 
 According to health facts 2008 from the Ministry of Health, cardiovascular 
disease is the main cause of death in Malaysia. From 2006-2010, 16872 patients with 
Acute Coronary Syndrome (ACS) were admitted to 17 tertiary centers in Malaysia.  
 The mean age of presentation for the different ACS presentations were 56 years 
(SD 12) for ST Elevation Myocardial Infarction (STEMI), 62 years (SD 12) for Non ST 
Elevation Myocardial Infarction (NSTEMI) and 61 years (SD 12) for unstable angina. 
Compared with the large, multicenter GRACE Registry and other Western registries, 
patients in Malaysia were younger (mean age in GRACE for STEMI: 65 years; 
NSTEMI: 68 years; unstable angina 66 years)  
 Referring to the Malaysian 5
th
 National Cardiovascular Disease Database on 
ACS (NCVD-ACS) registry from 2006 to 2010, majority of patients presented with 
STEMI (48%), followed by NSTEMI (30%) and unstable angina (22%). The same 
registry shows that patients with ACS had a male preponderance over female (76% 
male, 24% female).   
 Acute coronary syndrome defined as a clinical spectrum of ischemic heart 
disease which depending on the acuteness and severity of coronary vascular occlusion 
will cause either unstable angina, non ST segment elevation myocardial infarction or 
ST segment myocardial infarction.
1
 
 Overall, amongst the 4,000 or so STEMI patients, between years 2006-2010 in 
Malaysia, the median pain-to-needle time was 240 minutes (4 hours), whereas the 
median door-to-needle (DNT) was 50 minutes. The difference of pre-hospital pain-to-
door time was approximately 190 minutes (three hours).
2
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 The in-hospital mortality rate was highest in STEMI (8-10%), slightly lower in 
NSTEMI (6-9%), and lowest in UA (1-3%). At 30-day follow-up, the mortality rates 
were similar for both STEMI and NSTEMI (12% in average), and the rate was lowest in 
UA (3-6%).The mortality rate of ACS in Malaysia was higher than the mortality rates 
in several other global and regional ACS registries within the similar period. The 
expanded Global Registry of Acute Coronary Events (GRACE 2) from 2001 to 2007 
reported in-hospital mortality rate of 6.2% in STEMI, 2.9% in NSTEMI and 1.7% in 
unstable angina patients. 
 The National Cardiovascular Disease Database 2010 also mentioned that the in-
hospital and 30-day mortality following STEMI is also high at 10% and 14% 
respectively. These show the high disease burden of cardiovascular diseases.  
1.2 Literature Review 
 So far, the economic burden of Acute Coronary Syndrome in Malaysia is not 
well known but a study in Korea in 2009, shows the prevalence of ACS in Korea was 
6.4 persons per 1,000 population members and the associated mortality rate was 20.2 
persons per 100,000 population members. The total cost of ACS in 2009 was USD 
918.2 million. Of the total, direct medical cost was USD 425.3 million, direct non-
medical cost was USD 11.4 million, and cost associated with morbidity and mortality 
was USD 481.5 million.
3
 According to statistics from the American Heart Association 
(AHA), approximately 18% of men and 23% of women over the age of 40 will die 
within 1 year of having an initial recognized MI. The economic burden of ACS is also 
very high, costing Americans more than $150 billion, according to AHA estimates. 
Approximately 20% of the ACS patients are re hospitalized within 1 year, and nearly 60% 
of the costs related to ACS result from re hospitalization.
4
 In view of the high economic 
cost of ACS, efficient and effective treatment and prevention of ACS must be set in 
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place to reduce ACS mortality morbidity that plaques patients after the initial episode of 
Acute Coronary Syndrome. 
5
 
 A difference in gender will also predict the severity of MACE in ACS. It was 
found that women with non-obstructive Coronary Artery Disease (CAD) had a higher 
risk of MACE than men with non-obstructive CAD (adjusted HR 2.43, 95% CI 1.08-
5.49). 
6
 
 There are multiple co-morbidities that influence outcome for ACS. Data from 
observational studies and secondary analyses of randomized controlled trials (RCTs) 
have emerged that suggest that anemia is associated with higher rates of mortality, re-
infarction, and other adverse outcomes after ACS. A systemic review and meta analysis 
by Lawler et al.
7
 show that among clinical studies almost 20% of subjects with ACS has 
anemia. The presence of anemia is associated with a clinical and statistical increased 
risk for mortality after ACS which could be attributed at increased risk of re-infarction. 
Furthermore, there is evidence that as anemia worsen the outcome also worsen. Thus 
correction of anemia could improve short and long term outcomes.  
 In a retrospective study conducted using Western Denmark health care database, 
there was an association that suggest significantly worse outcome for patient with 
STEMI who undergo Percutaneous Coronary Intervention (PCI) with underlying 
Diabetes Mellitus (DM) compared to those who do not have DM. All-cause mortality 
was 23.7% in patients with DM, vs. 12.7% in patients without DM (adjusted HR 2.03, 
95% CI 1.59–2.59).8 These findings might suggest that more aggressive treatment and 
vigilance be given to those patients who present with ACS and underlying DM.   
 In the VALIANT (Valsartan in Acute Myocardial Infarct Trial) Trial it was 
found that decreasing Gomerular Filtration Rate (GFR) was associated with increasing 
mortality rates.
9
 It was concluded that preexisting renal disease was a common and 
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significant independent risk factor for adverse events in patients who had had a 
myocardial infarction complicated by heart failure, left ventricular systolic dysfunction, 
or both.
10
 
 In regards to heart failure severity in ACS, the Killip classification is an 
important independent predictor of 30 day mortality. Higher Killip class was associated 
with higher mortality at 30 days (2.8% in Killip class I vs 8.8% in class II vs 14.4% in 
class III/IV; P<.001) and 6 months (5.0% vs 14.7% vs 23.0%, respectively; P<.001).
11
 
 Advancement in treatment of Acute Myocardial Infarction (AMI) has enabled 
health care providers to reduce the high mortality that was used to be associated with 
AMI.  Survival rates from AMI are improved by 50% if reperfusion with Alteplase is 
achieved within 1 hour of symptom onset and 23% if achieved within 3 hours of 
symptoms onset.
12
 
 Time is of the utmost importance as more time passes more ischaemic 
myocardium get irreversibly damage and results in worsen outcome. Every minute 
delay in treatment of patients with STEMI does influence 1 year mortality, not only in 
thrombolytic therapy but also in primary angioplasty. The risk of 1-year mortality is 
increased by 7.5% for each 30-minute delay. Therefore all efforts should be made to 
shorten the total ischemic time, not only for thrombolysis but also for primary 
angioplasty.
 13
 
 In a study to see factors influencing emergency department arrival and in 
hospital management of AMI, the median delay was from onset of symptoms to 
hospital arrival was 110 minutes (approximately 2 h). Only 22% of patients arrived to 
the hospital within the first hour.  According to the results of this study, many patients 
with AMI who may be eligible for reperfusion therapy miss the "golden hour" because 
of late hospital arrival. Some groups of patients (i.e., elderly, women, those with 
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diabetes) were especially late in arriving.
14
 As such any delay in the treatment of 
patients with AMI must be identified and rectified.  
 The mean ambulance response time of Emergency Medical Services team of 
Hospital Universiti Sains Malaysia (HUSM) was 15.2 minutes in 2004-2005.
15
 This is 
below the standard mean ambulance time of 8 minutes recommended by international 
standards. 
16,17
 
 The recommended eight minute cut off time for ambulance response time 
originated from the study by Eisenberg et al. in 1978. Eisenberg found that survival 
from witnessed out of hospital cardiac arrest of medical origin was maximized if the 
time from cardiac arrest to start of CPR was four minutes and the time from cardiac 
arrest to definitive care (eg. Defibrillation) was eight minutes.
18
  This time was later 
extended to all life threatening events whether medical or traumatic in origin which is 
currently the international cut off point for good ambulance response time. 
 For any health emergencies that require the ambulance services, is it assume that 
the faster the ambulance response time, the better the patient outcome especially in 
regards to survival to hospital discharge. However, a study by Blanchard et al. in 2012 
shows that ambulance response time does not have an association with survival 
outcome in life threatening events. For patients with a response time ≥ 8 minutes, 7.1% 
died, compared with 6.4% for patients with a response time ≤ 7 minutes 59 seconds 
(risk difference 0.7%; 95% confidence interval [CI]: –0.5%, 2.0%). The adjusted odds 
ratio of mortality for ≥ 8 minutes was 1.19 (95% CI: 0.97, 1.47).16 Another study by 
Pons and colleagues 
19
 also states that paramedic response time within eight minutes 
was not associated with improved survival to hospital discharge even after controlling 
for several important confounders, including level of illness severity. However the due 
to the diverse number of diseases that the pre-hospital services attend to, the  authors 
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also concluded that more studies must be done to ascertain whether there are particular 
diseases that truly does benefit from speedy ambulance response time.  
 As the phrase, Time is Myocardium is used frequently to denote rapid medical 
intervention can help to limit the severity of damage to the ischaemia myocardium in 
Acute Coronary syndromes, it is worthwhile to study whether a true association exist 
between faster ambulance response time and presence of adverse cardiac events in 
patients who has Acute Coronary Syndrome. 
 The economic burden to maintain a pre-hospital service that has rapid response 
to all life threatening conditions can be reduced if there are more selective in choosing 
cases that truly warrant immediate pre-hospital activation instead of having to strain all 
the resources to respond to all cases quickly all the time.  
 Acute Coronary Syndrome is a time sensitive disease with worse outcome when 
the time from onset of symptoms to arrival to Emergency Department becomes longer. 
This study is to establish whether there is any association between ambulance response 
time and occurrence of MACE among ACS patient who used the ambulance services.  
1.3 Research Questions 
1. What is the current mean ambulance response time for complaints of chest pain 
or symptoms that suggest cardiovascular diseases? 
2. Is there any association between ambulance response time and occurrence of 
MACE for among patient with ACS who used the ambulance services?  
3. Is there any association between gender, anemia, renal failure, dyslipidemia, 
heart failure and occurrence of MACE in ACS patients who used the ambulance 
services? 
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1.4 Study Objectives 
 i. General Objective:  
To identify ambulance response time within the areas covered by Hospital 
Universiti Sains Malaysia and Hospital Raja Permaisuri Bainun (HRBP) in 
regards to patients with ACS. 
 ii. Specific objectives:  
1. To determine the average ambulance response time for patients with 
ACS for HUSM and HRPB. 
2. To determine the association between ambulance response time and 
MACE in ACS who used ambulance services. 
3. To determine factors associated with occurrence of MACE in ACS 
patients who used the ambulance services.  
1.5 Methodology 
 Study Population 
 This is a retrospective cohort study from January 2014 until December 2016. 
The study will be conducted in two major capital cities in Malaysia, namely Kota Bharu 
and Ipoh where the EMS system were based in Hospital Universiti Sains Malaysia 
(HUSM) and Hospital Raja Permaisuri Bainun (HRPB) respectively. Kota Bharu has a 
total population of 491,234 while that of Ipoh has 659,892.
20
 
 All the ambulance units are equipped with Advanced Cardiac Life Support 
(ACLS) equipment and manned by dedicated ambulance driver and 2 ACLS trained 
EMS providers. Convenient sampling will be used in this study where all 999 calls with 
symptoms of ACS during the study period were included. Trained EMS call takers who 
determined ACS symptoms from a written EMS directive handled all the covered calls. 
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   The study includes all EMS cases with the age of above 18 years old that were 
diagnosed as having ACS. The ART will be obtained from the dispatcher information 
sheet. Patients’ age, gender, co-morbidities, admission diagnosis, treatments given, and 
event of MACE will be obtained from patients’ in-hospital record. MACE was 
determined at 30 and 90 days after initial presentation. 
 The sample size was determined based on the objective of estimating the 
average ART in our study population. Based on a previous study, the ART was 15.22 
minutes (SD=4.6 minutes).
15
 To estimate the average ART with type I error of 5% and 
precision of estimation of ± 1 minute, and the required sample size was 103 after 
accounting for 20% drop out. 
 Statistical analysis 
 Data entry and analysis will be conducted using Statistical Package for Social 
Sciences (SPSS) version 22. The data will be explored to look for errors in data entry 
and to determine the pattern of distribution of numerical variables (age and ART).  
Based on histogram and test of normality which showed normal distribution of these 
numerical variables, they will be presented as mean (SD). Categorical variables will be 
presented as number and percentage (%). Simple and multiple binary logistic regression 
analysis will be applied in determining factors associated with the probability of 
developing MACE at 30 and 90 days post-ACS. At univariable analysis, variables with 
p<0.25 were selected to be included in the multivariable analysis for variable selection 
using forward and backward LR method. Multicollinearity of all independent variables 
will be checked using correlation matrix, and interaction will be checked using a 
multiplicative method. The Model fitness was then analyzed using the Hosmer-
Lemeshow goodness of fit 2 test, classification table, and area under Receiver 
9 
 
Operation (ROC) curve. Categorical variables are presented in numbers (n) and 
percentages (%), and continuous variables in means with the standard deviation (SD). 
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Chapter 2 
Study Protocol 
2.1 Document submitted for ethical approval 
Study proposal  
Topic: Association of Ambulance Response Time and Major Adverse Cardiac Events in 
Acute Coronary Syndrome 
Sponsor: Self-funding 
Principle Investigator: Dr. Jeremiah Ding Deck Shen  
Institution: Department of Emergency Medicine, School of Medical Sciences, 
Universiti Sains Malaysia 
Introduction 
 According to health facts 2008 from the Ministry of Health, cardiovascular 
disease is the main cause of death in Malaysia. From year 2006 to year 2010, 16872 
patients with Acute Coronary Syndrome (ACS) were admitted to 17 tertiary centers in 
Malaysia. 
 The mean age of presentation for the different ACS presentations were 56 years 
(SD 12) for ST Elevation Myocardial infarction (STEMI), 62 years (SD 12) for Non ST 
Elevation Myocardial Infarction (NSTEMI) and 61 years (SD 12) for unstable angina. 
Compared with the large, multicenter GRACE Registry and other Western registries, 
patients in Malaysia were younger (mean age in GRACE for STEMI: 65 years; 
NSTEMI: 68 years; unstable angina 66 years)  
 Referring to Malaysian 5
th
 National Cardiovascular Disease Database on ACS 
(NCVD-ACS) registry (NCVD-ACS) registry from 2006 to 2010, majority of patients 
presented with STEMI (48%), followed by NSTEMI (30%) and unstable angina (22%). 
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The same registry shows that patients with ACS had a male preponderance over female 
(76% male, 24% female).  
 A variety of coronary risk factors exist for ACS. Of patients with ACS, it is 
noted 33% were active smokers, 22% were former smokers, while 39% never smoked. 
On the same note, 33% were previously diagnosed with dyslipidaemia, 61% with 
hypertension, 43% with diabetes and 11% had a family history of premature coronary 
artery disease.  
 The Emergency Medical Services (EMS) of HUSM is one of the services 
provided by HUSM to cater for the demands of transporting patients who require 
medical assistance to the Emergency Department for further treatment. The total 
coverage area of HUSM services is 65,000 km
2 
with a total of 9 functioning ambulances 
to serve the needs of the community during emergencies. The mean ambulance 
response time of EMD team was 15.2 minutes in 2004-2005.
1
 On the same note, mean 
ambulance response time in Singapore was 15 minutes and UK was 7-11 minutes.  
Literature review 
 Acute coronary syndrome (ACS) defined as a clinical spectrum of ischemic 
heart disease which depending on the acuteness and severity of coronary vascular 
occlusion will cause either unstable angina, non ST segment elevation myocardial 
infarction or ST segment myocardial infarction.
2
 
 Overall, amongst the 4,000 or so STEMI patients, between years 2006-2010 in 
Malaysia, the median pain-to-needle time was 240 minutes (4 hours), whereas the 
median door-to-needle (DNT) was 50 minutes. The difference of pre-hospital pain-to-
door time was approximately 190 minutes (three hours).
3
  
 The in-hospital mortality rate was highest in STEMI (8-10%), slightly lower in 
NSTEMI (6-9%), and lowest in UA (1-3%). At 30-day follow-up, the mortality rates 
14 
 
were similar for both STEMI and NSTEMI (12% in average), and the rate was lowest in 
UA (3-6%).The mortality rate of ACS in Malaysia was higher than the mortality rates 
in several other global and regional ACS registries within the similar period. The 
expanded Global Registry of Acute Coronary Events (GRACE 2) from 2001 to 2007 
reported in-hospital mortality rate of 6.2% in STEMI, 2.9% in NSTEMI and 1.7% in 
unstable angina patients. 
 The National Cardiovascular Disease Database 2010 also mentioned that the in-
hospital and 30-day mortality following STEMI is also high at 10% and 14% 
respectively. These show the high disease burden of cardiovascular diseases.  
 So far, the economic burden of Acute Coronary Syndrome in Malaysia is not 
well known but a study in Korea in 2009, shows the prevalence of ACS in Korea was 
6.4 persons per 1,000 population members and the associated mortality rate was 20.2 
persons per 100,000 population members. The total cost of ACS in 2009 was USD 
918.2 million. Of the total, direct medical cost was USD 425.3 million, direct non-
medical cost was USD 11.4 million, and cost associated with morbidity and mortality 
was USD 481.5 million.
4
 According to statistics from the American Heart Association 
(AHA), approximately 18% of men and 23% of women over the age of 40 will die 
within 1 year of having an initial recognized MI. The economic burden of ACS is also 
very high, costing Americans more than $150 billion, according to AHA estimates. 
Approximately 20% of the ACS patients are re hospitalized within 1 year, and nearly 60% 
of the costs related to ACS result from re hospitalization.
5
 In view of the high economic 
cost of ACS, efficient and effective treatment and prevention of ACS must be set in 
place to reduce ACS mortality morbidity that plaques patients after the initial episode of 
ACS. 
6
 
15 
 
 A difference in gender will also predict the severity of Major Adverse Cardiac 
Events (MACE) in ACS. It was found that women with non-obstructive Coronary 
Artery Disease (CAD) had a higher risk of MACE than men with non-obstructive CAD 
(adjusted HR 2.43, 95% CI 1.08-5.49).
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 There are many co morbidities that influence the outcome for ACS. Data from 
observational studies and secondary analyses of randomized controlled trials (RCTs) 
have emerged that suggest that anemia is associated with higher rates of mortality, re-
infarction, and other adverse outcomes after ACS. A systemic review and meta analysis 
by Lawler 
8
 shows that among clinical studies almost 20% of subjects with ACS has 
anemia. The presence of anemia is associated with a clinical and statistical increased 
risk for mortality after ACS which could be attributed at increased risk of re-infarction. 
Furthermore, there is evidence that as anemia worsens, the outcome also worsen. Thus 
correction of anemia could improve short and long term outcomes.  
 In a retrospective study conducted using Western Denmark health care database, 
there was an association that suggest significantly worse outcome for patient with 
STEMI who undergo PCI with underlying Diabetes Mellitus (DM) compared to those 
who do not have Diabetes Mellitus. All-cause mortality was 23.7% in patients with DM, 
vs. 12.7% in patients without DM (adjusted HR 2.03, 95% CI 1.59–2.59).9 This finding 
might suggest that more aggressive treatment and vigilance be given to those patients 
who present with ACS and underlying DM.  
 In the VALIANT (Valsartan in Acute Myocardial Infarct Trial) Trial it was 
found that decreasing Glomerular Filtration Rate (GFR) was associated with increasing 
mortality rates.
10
 It was concluded that preexisting renal disease was a common and 
significant independent risk factor for adverse events in patients who had had a 
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myocardial infarction complicated by heart failure, left ventricular systolic dysfunction, 
or both.
11
 
 Patient population with chest pain and ACS comes to the emergency department 
with a myriad of underlying co morbidities that will influence the clinical outcome. 
Thus risk scoring systems such as TIMI (Thrombolysis in Myocardial Infarction) will 
help to predict the outcomes of such patients.  The TIMI risk score at ED presentation 
successfully risk-stratified this unselected cohort of chest pain patients with respect to 
30-day adverse outcome, with a range from 2.1%, with a score of 0, to 100%, with a 
score of 7. The highest correlation of an individual TIMI risk indicator to adverse 
outcome was for elevated cardiac biomarker at admission.
12
 
 In regards to heart failure severity in Acute Coronary Syndrome, the Killip 
classification is an important independent predictor of 30 day mortality.  Higher Killip 
class was associated with higher mortality at 30 days (2.8% in Killip class I vs 8.8% in 
class II vs 14.4% in class III/IV; P<.001) and 6 months (5.0% vs 14.7% vs 23.0%, 
respectively; P<.001).
13
 
 Advancement in treatment of Acute Myocardial Infarction has enabled health 
care providers to reduce the high mortality that was used to be associated with Acute 
Myocardial Infarction (AMI). Survival rates from AMI are improved by 50% if 
reperfusion with Alteplase is achieved within 1 hour of symptom onset and 23% if 
achieved within 3 hours of symptoms onset.
14
 
 Time is of the utmost importance as more time passes more ischaemic 
myocardium get irreversibly damage and results in worsen outcome. Every minute 
delay in treatment of patients with STEMI does influence 1 year mortality, not only in 
thrombolytic therapy but also in primary angioplasty. The risk of 1-year mortality is 
increased by 7.5% for each 30-minute delay. Therefore all efforts should be made to 
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shorten the total ischemic time, not only for thrombolysis but also for primary 
angioplasty.
 15
 
 In a study to see factors influencing emergency department arrival and in 
hospital management of AMI, the median delay was from onset of symptoms to 
hospital arrival was 110 minutes (approximately 2 hours). Only 22% of patients arrived 
to the hospital within the first hour.  According to the results of this study, many 
patients with AMI who may be eligible for reperfusion therapy miss the "golden hour" 
because of late hospital arrival. Some groups of patients (i.e. elderly, women, those with 
diabetes) were especially late in arriving.
16
 As such any delay in the treatment of 
patients with AMI must be identified and rectified.  
 One of the reasons that results in delay of treatment will be access to 
transportation. In a study in East Tennessee, approximately 15% of the study population 
did not have timely geographic accessibility to emergency cardiac care. Populations 
with poor access were located in rural areas.
17  
This reflects the area surrounding HUSM 
which is still considered a rural area. Also as distance from hospital increases, MACE 
and mortality rates among ACS patients become higher.
18
 
 The mean ambulance response time of EMS team of HUSM was 15.2 minutes 
in 2004-2005
14
 which is below the standard mean ambulance time of eight minutes 
recommended by international standards.
19 ,20
 
 The recommended eight minute cut-off time for ambulance response time 
originated from the study by Eisenberg et al. in 1978. Eisenberg found that survival 
from witnessed out of hospital cardiac arrest of medical origin was maximized if the 
time from cardiac arrest to start of CPR was four minutes and the time from cardiac 
arrest to definitive care (eg. Defibrillation) was eight minutes.
21
  This time was later 
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extended to all life threatening events whether medical or traumatic in origin which is 
currently the international cut-off point for good ambulance response time.  
Rational of study  
 For any health emergencies that require the ambulance services, is it assume that 
the faster the ambulance response time, the better the patient outcome especially in 
regards to survival to hospital discharge. However, a study by Blanchard et al. in 2012 
shows that ambulance response time does not have an association with survival 
outcome in life threatening events. For patients with a response time ≥ 8 minutes, 7.1% 
died, compared with 6.4% for patients with a response time ≤7minutes 59 seconds 
(risk difference 0.7%; 95% confidence interval [CI]: –0.5%, 2.0%). The adjusted odds 
ratio of mortality for ≥ 8 minutes was 1.19 (95% CI: 0.97, 1.47).19 Another study by 
Pons and colleagues 
22
 also states that paramedic response time within 8 minutes was 
not associated with improved survival to hospital discharge even after controlling for 
several important confounders, including level of illness severity. However the due to 
the diverse number of diseases that the pre-hospital services attend to, the  authors also 
concluded that more studies must be done to ascertain whether there are particular 
diseases that truly does benefit from speedy ambulance response time.  
 As the phrase, Time is Myocardium is used frequently to denote rapid medical 
intervention can help to limit the severity of damage to the ischaemia myocardium in 
ACS, it is worthwhile to study whether a true association exist between faster 
ambulance response time and occurrence of adverse cardiac events in patients who has 
ACS. 
 The economic burden to maintain a pre-hospital service that has rapid response 
to all life threatening conditions can be reduced if there are more selective in choosing 
19 
 
cases that truly warrant immediate pre-hospital activation instead of having to strain all 
the resources to respond to all cases quickly all the time.  
 Acute Myocardial Infarction is a time sensitive disease with worse outcome 
when the time from onset of symptoms to arrival to Emergency Department becomes 
longer. Thus the pre-hospital services can be an avenue to reduce the national pain to 
needle time which in the end will help to reduce the mortality and morbidity of ACS 
and also the financial burden of ACS. 
23
 
  Lastly, after knowing the ambulance access time, it will be used to gauge the 
efficacy of the ambulance services of HUSM and also HRPB in comparison to 
international standards and also to assess whether there has been any improvement 
since the last study by Shah et al. 2008.   
Research Questions: 
1. What is the current mean ambulance response time for complaints of chest 
pain or symptoms that suggest cardiovascular diseases? 
2. Is there any association between ambulance response time and MACE for 
patient with acute coronary syndromes? 
3. Is there any association between gender, underlying comorbidity, ambulance 
access time and Killip classification to rates of MACE in acute coronary 
patients? 
Hypothesis 
1. The faster the response ambulance time, the lower the rate of MACEs. 
2. Female gender and higher number of underlying comorbidity have higher rate of 
MACEs. 
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Study Objectives 
 i. General Objective:  
To identify ambulance response time within the areas covered by Hospital 
Universiti Sains Malaysia (HUSM) and Hospital Raja Permaisuri Bainun 
(HRBP) regarding patients with of Acute Coronary Syndrome. 
 ii. Specific objectives:  
1. To determine the average ambulance response time for patients with 
ACS. 
2. To determine the association between ambulance response time and 
MACE in ACS. 
3. To determine factors associated with MACE occurrence in ACS patients 
who used ambulance services. 
Methodology 
i. Study design: retrospective study (both exposure and outcome had already 
occurred prior to the commencement of the study). 
ii. Target group: Patients with Acute Coronary Syndrome 
(UA/STEMI/NSTEMI). 
iii. Source population: All patients with acute coronary syndrome presented to 
HUSM and HRPB who used the ambulance service from 2014-2016. 
iv. Location of study: Areas covered by HUSM and HRPB health services. 
v. Data collection: Looking through the case notes of patients presented to 
HUSM and HRPB using the ambulance service with UA/NSTEMI/ STEMI 
as primary data.  
vi. Sampling methods 
21 
 
1. Inclusion criteria: All cases of confirmed Acute Coronary Syndrome 
admitted to HSUM and HRBP during the study period will be 
included in the study. 
2. Exclusion criteria : Patients not residents of Kelantan and Perak. 
vii. Research analysis:  
1. Objective1 : Descriptive statistics 
2. Objective 2 and 3 : Multiple logistic regression 
viii. Sample Size determination 
1. Objective 1 : ambulance response time of HUSM 
-  
-Z = 1.96, CL: 95% 
-SD = 4.6 min.
1
 
-Precision = 1 min  
Sample size = 81 + 20% = 103 
 
2. Objective  2: Association of ambulance response time with MACE in ACS, 
retrospective cohort, 2 proportions  
   - alpha = 0.05 ( 2 sided )  
  - power = 0.8 
  - ratio : 1 
  - P0 = 0.06 ( proportion of patient with ambulance response time < 8 
minutes with mortality).
19
   
  - P1 = 0.3 ( estimated proportion of patient that HUSM ambulance service 
ambulance response time > 8 minutes with MACE)  
 - sample size = 78 + 20 % = 94 
3. Objective  3:  Association of other factors to MACE in ACS 
i) gender 
22 
 
-  alpha = 0.05 ( 2 sided) 
- power = 0.8 
- ratio =1 
- P0 = 0.3 ( proportion of  STEMI who are female ).
24
 
- P1 = 0.7 ( estimated proportion of STEMI who are men )  
- sample size = 46 + 20% = 55 
 
ii) anemia 
Alpha – 0.05 
Power = 0.8 
Ratio = 1 
P0= 0.01 ( proportion of ACS patient who has no anemia and have 
MACE ).
25
 
P1 = 0.2 ( estiamted ACS patient with anemia and MACE )  
Sample size = 80 + 20 % =  100 
 
iii) Diabetes 
Alpha = 0.05 
Power = 0.8 
Ratio = 1 
P0 = 0.16( Proportion of patient  without diabetes with MACE in post 
MI ).
26
 
P1 = 0.5 ( estimated proportion of MACE in diabetic patient post ACS )  
Sample size = 76 + 20% = 91 
ix.  Research Instruments: Statistical Package for Social Science (SPSS) 22.  
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Definition 
1. Acute Myocardial Infarction is used when there is evidence of myocardial 
necrosis in a clinical setting that consistent with myocardial ischaemia. The 
diagnosis includes biochemical cardiac markers of myocardial necrosis, 
symptoms consistent with myocardial ischaemia, cardiac imaging, ECG changes 
and intracoronary thrombus upon autopsy/ angioplasty.
27
 
2. ECG criteria for STEMI: ST-segment elevation or presumed new LBBB is 
characterized by ST-segment elevation in 2 or more contiguous leads Threshold 
values for ST-segment elevation consistent with STEMI are J-point elevation 
0.2 mV (2 mm) in leads V2 and V3 and 0.1 mV (1 mm) in all other leads 
(men40 years old); J-point elevation 0.25 mV (2.5 mm) in leads V2 and V3 and 
0.1 mV (1 mm) in all other leads (men 40 years old); J-point elevation 0.15 mV 
(1.5mm) in leads V2 and V3 and 0.1 mV (1 mm) in all other leads (women).
27
 
3. ECG criteria for Unstable Angina/NSTEMI: ST-segment depression 0.5 mm 
(0.05 mV) or dynamic T-wave inversion with pain or discomfort is classified as 
UA/NSTEMI. Non persistent or transient ST-segment elevation 0.5 mm for 20 
minutes is also included in this category. Threshold values for ST-segment 
depression consistent with ischemia are J-point depression 0.05 mV (-.5 mm) in 
leads V2 and V3 and -0.1 mV (-1 mm) in all other leads (men and women).
27
 
4. MACE (major adverse cardiac events): Death (not clearly non-cardiac), cardiac 
arrest, an emergency re-vascularisation procedure, cardiogenic shock, 
ventricular arrhythmia needing intervention, high-degree atrio ventricular block 
needing intervention and acute myocardial infarction within 30 days from 
primary event, as cited from 
28
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5. Ambulance response time: Defined as time taken from receiving the emergency 
call, till time of arrival to incident site. Includes call processing time, time to 
prepare a team , time to travel to scene.
29
  
6. Time at the scene: The period between ambulance arrival at the scene and 
ambulance departure from the scene.
29
 
7. Transport time: the interval between leaving the scene and arriving at the 
emergency department.
29
 
8. Total run time: response time, scene time and transport time which amount to 
the total run time.
29
 
Conclusion, Discussion, Future Recommendation 
Data supporting the association between longer ambulance access time and worse 
outcomes in Acute Myocardial Infarction will drive more efforts to improve ambulance 
services and also to get the appropriate funding and supports that it deserves.    
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